Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nursing students' use of products and substances to reduce stress or improve cognition during exam periods.

Nurse education in practice·2024
Same author

<i>Advances in Respiratory Medicine</i>-Aims and Scopes Update.

Advances in respiratory medicine·2024
Same author

Awareness and Attitude of Polish Gynecologists and General Practitioners towards Human Papillomavirus Vaccinations.

Healthcare (Basel, Switzerland)·2023
Same author

Evaluation of Polish Adolescents' Knowledge About Human Papillomavirus and Vaccines.

Journal of adolescent and young adult oncology·2022
Same author

Knowledge and Awareness of Polish Parents on Vaccination against Human Papillomavirus.

Vaccines·2022
Same author

Human papillomavirus vaccination - limatations and opportunities in countries with low vaccine coverage.

Przeglad epidemiologiczny·2022

Related Experiment Video

Updated: Jun 24, 2026

Angiogenesis in the Ischemic Rat Lung
07:36

Angiogenesis in the Ischemic Rat Lung

Published on: February 8, 2013

[Angiogenesis in interstitial lung diseases].

Tadeusz M Zielonka1

  • 1Katedra i Zakład Medycyny Rodzinnej Warszawskiego Uniwersytetu Medycznego. tmzielonka@wp.pl

Pneumonologia I Alergologia Polska
|March 25, 2009
PubMed
Summary

Interstitial lung diseases (ILD) involve inflammation and fibrosis, leading to hypoxia. New research highlights the role of neoangiogenesis in ILD, suggesting potential therapeutic targets like antiangiogenic drugs.

Area of Science:

  • Pulmonary Medicine
  • Pathophysiology
  • Oncology

Background:

  • Interstitial lung diseases (ILD) are a diverse group of lung disorders.
  • Inflammation and pulmonary fibrosis are key pathological processes in ILD.
  • ILD impairs gas exchange, causing hypoxia.

Purpose of the Study:

  • To explore the role of neoangiogenesis in the pathogenesis of ILD.
  • To investigate the link between ILD, fibrosis, and abnormal wound healing.
  • To identify potential therapeutic targets for ILD based on angiogenesis.

Main Methods:

  • Review of existing literature on ILD, fibrosis, and angiogenesis.
  • Analysis of the relationship between chronic inflammation, hypoxia, and neovascularization in the lungs.

More Related Videos

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
07:52

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis

Published on: December 21, 2014

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Related Experiment Videos

Last Updated: Jun 24, 2026

Angiogenesis in the Ischemic Rat Lung
07:36

Angiogenesis in the Ischemic Rat Lung

Published on: February 8, 2013

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
07:52

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis

Published on: December 21, 2014

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

  • Examination of the role of angiogenesis in idiopathic pulmonary fibrosis and other ILDs.
  • Main Results:

    • Chronic inflammation and hypoxia in ILD stimulate neovascularization (angiogenesis).
    • Angiogenesis is implicated in the pathogenesis of idiopathic pulmonary fibrosis and other ILDs like granulomatosis, fibrosis, and vasculitis.
    • The precise mechanisms of angiogenesis in ILD require further elucidation.

    Conclusions:

    • Neoangiogenesis plays a significant role in the development and progression of ILD.
    • Understanding angiogenesis in ILD opens avenues for novel therapeutic strategies.
    • Antiangiogenic agents, such as thalidomide, show promise in managing certain ILD cases.